Intraocular Lens Market Size & Share, by Type (Monofocal, Premium), Material (Polymethylmethacrylate, Silicon, Hydrophobic & Hydrophilic Acrylic Materials), End-user (Hospitals, Ambulatory Surgery Centers, Ophthalmology Clinics, Eye Research Institutes) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2025-2037

  • Report ID: 4856
  • Published Date: Oct 14, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2025-2037

Intraocular Lens Market size was valued at USD 6.57 billion in 2024 and is set to reach USD 18.66 billion by the end of 2037, expanding at around 8.3% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of intraocular lens is assessed at USD 7.01 billion.

The growth of the market can be attributed to growing prevalence of eye disease which includes macular degeneration, diabetic retinopathy, and glaucoma. For instance, by 2030, there is expected to be 191.0 million people with DR (diabetic retinopathy) worldwide. Diabetes patients who have persistently high blood sugar levels may develop diabetic retinopathy, which damages the blood vessels in the retina of the eye.

Further, these eyes disease could also lead a formation of cataract which could further boost the demand for cataract surgery. One of the most frequent eye surgery operations worldwide is cataract removal. This surgery is performed over 3 million times a year in the United States alone, and about 27 million times worldwide. Every day, about 59,999 cataract surgeries are performed internationally. Improved vision is the main goal of cataract surgery, which is accomplished by removing the clouded lens and replacing it with a clear IOL. The IOL increases visual acuity and enables patients to see clearly by correcting the eye's refractive defect.


Get more information on this report: Request Free Sample PDF

Intraocular Lens Sector: Growth Drivers and Challenges

Growth Drivers

  • Growing Prevalence of Diabetes - In 2021, there were about 536 million adults (20-79 years old) who had diabetes. According to projections, there would be approximately 642 million diabetics worldwide by 2030 and about 782 million by 2045. Diabetes is a major risk factor for several eye problems, including cataracts and diabetic retinopathy, which is why there is an increasing demand for intraocular lenses as the prevalence of the disease rises. The demand for therapeutic options including intraocular lenses rises along with the prevalence of diabetes since more people with diabetes are at risk for developing these eye diseases.
  • Rising Geriatric Population - According to the World Health Organization, one in six persons on the planet would be 60 years of age or older by the year 2030. At this point, there would be 1.4 billion people, up from 1 billion in 2020, who are 60 years of age or older. Age is a major risk factor for cataracts, which are the main cause of vision loss in older persons, hence the growing geriatric population is driving up demand for intraocular lenses. The lens of the eye could become clouded and less flexible as we age, which impairs vision and makes things murky.
  • Surge in Screen Exposure - People worldwide spend about 7 hours, 58 minutes every day in front of a screen. Since 2013 till 2023, daily screen time has climbed by about 49 minutes. The demand for intraocular lenses is rising as more people are exposed to screens, primarily since prolonged use of electronic screens, such as those on computers and mobile devices, may increase the incidence of vision issues such as presbyopia (age-related loss of near vision) and asthenopia (eye strain).
  • Growth in Medical Tourist - Approximately 3 million patients travel to India annually from about 77 different countries for medical, wellness, and IVF treatments. 
  • Upsurge in Disposable Income - In the United States, disposable personal income climbed to about USD 19706 billion in February 2023 from approximately USD 19616 billion in January 2023. People are inclined to choose modern IOLs that provide greater vision correction and higher quality of life when disposable income increases.

Challenges

  • High Cost of Intraocular Lens
  • Regulatory Barriers - Some manufacturers may find it difficult to launch new items into the intraocular lens market since the regulatory approval procedure for medical devices such intraocular lenses may be time-consuming and expensive. Additionally, regulatory regulations may differ from nation to nation, adding to the entry obstacles for manufacturers. Hence, this factor is estimated to hinder the growth of the market.
  • Lack of Awareness Among People

Intraocular Lens Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

CAGR

8.3%

Base Year Market Size (2024)

USD 6.57 billion

Forecast Year Market Size (2037)

USD 18.66 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Intraocular Lens Segmentation

End-user (Hospitals, Ambulatory Surgery Centers, Ophthalmology Clinics, Eye Research Institutes)

The global intraocular lens market is segmented and analyzed for demand and supply by end user into hospitals, ambulatory surgery centers, ophthalmology clinics, and eye research institutes. Out of which, the hospital segment is anticipated to garner the highest revenue by the end of 2037. The growth of the segment can be attributed to growing cataract surgeries in hospitals. In India in 2022, charitable hospitals did over 1 lakh cataract surgery procedures while private hospitals handled about 3 lakh. Many hospitals have a group of qualified and experienced surgeons that specialize in cataract operations. When a patient receives care from a surgeon who has a great deal of experience and expertise carrying out these treatments, the patient may feel more secure in the surgical outcomes. Moreover, patients need follow-up care after cataract surgery to check on their progress and make sure the procedure was successful. Hospitals frequently offer specialized follow-up clinics and support services to aid patients in their recovery and handle any issues that may occur.

Type (Monofocal, Premium)

The global intraocular lens market is also segmented and analyzed for demand and supply by type into monofocal intraocular lens, and premium intraocular lens. Amongst which, the monofocal intraocular lens segment is expected to have the significant growth over the forecast period. Comparatively to multifocal or accommodating IOLs, monofocal IOLs have a lower risk of producing visual disturbances such halos, glare, and diminished contrast sensitivity. Moreover, when compared to multifocal or accommodating IOLs, monofocal IOLs are less likely to have issues including lens displacement. Additionally, the needs and desires of the patient may be taken into consideration while designing monofocal IOLs. Depending on the patient's lifestyle and visual needs, they could be chosen to give clear distance vision, clear near vision, or a balance between the two.

Our in-depth analysis of the global market includes the following segments:

        By Type

  • Monofocal Intraocular Lens
  • Premium Intraocular Lens

 

 

        By Material

  • Polymethylmethacrylate
  • Silicon
  • Hydrophobic & Hydrophilic Acrylic Materials

 

        By End User

  • Hospitals
  • Ambulatory Surgery Centers
  • Ophthalmology Clinics
  • Eye Research Institutes

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Intraocular Lens Industry - Regional Synopsis

North American Market Forecast

The intraocular lens market in North America is projected to have the growth by the end of 2037, backed by growing healthcare investment, along with rising prevalence of cataracts. In 2021, the United States spent about 3% more on health care, amounting to approximately USD 3 trillion or about USD 12,913 per person. In North America, minimally invasive surgery methods such as femtosecond laser-assisted cataract surgery (FLACS) and microincision cataract surgery (MICS) are becoming more and more common. Compared to conventional cataract surgery, these approaches are more precise, safe, and they frequently demand for the use of expensive IOLs to produce the best results. Moreover, owing to the growing disposable income of people in this region their demand for premium IOLs is growing. Additionally, IOLs and cataract surgery are usually covered by favorable reimbursement rules in North America, which has expanded the use of premium IOLs among patients and medical professionals.

Europe Market Forecast

The European intraocular lens market is estimated to be the second largest, to have the highest growth over the forecast period. The need for cataract surgery and IOLs is being driven by the ageing of the European population. Age-related clouding of the natural lens of the eye could lead to cataracts, which could impair vision. The hazy lens is replaced with an IOL to improve vision. In addition, Europe is home to a large number of creative businesses and research organizations that are creating new and sophisticated IOLs. Patients and surgeons are turning to these new technologies to get better visual results, which is propelling market expansion.

APAC Market Statistics

Additionally, the intraocular lens market in Asia Pacific region is also estimated to have the significant growth over the forecast period. Eye conditions include cataracts, diabetic retinopathy, and age-related macular degeneration are very common in the Asia Pacific region. As more people are given the diagnosis of having these illnesses, this is increasing the demand for cataract surgery and IOLs. Additionally, a lot of nations in the Asia-Pacific region are well-liked spots for medical tourism, particularly for eye surgery. As more people travel to this region for cataract surgery and IOL implantation, this is fueling market growth. Moreover, the insurance coverage for cataract surgery and IOLs is expanding in several nations around the Asia-Pacific region. More people are able to obtain these services through their insurance policies as a result, which is fueling intraocular lens market expansion.

Research Nester
Get more information on this report: Request Free Sample PDF

Companies Dominating the Intraocular Lens Landscape

    • Alcon Vision LLC
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Johnson & Johnson Vision Care Inc.
    • Bausch Health Companies Inc.
    • Carl Zeiss Meditec AG
    • HOYA Corporation
    • Rayner Group
    • STAAR Surgical Company
    • PhysIOL SA
    • Lenstec Inc.
    • HumanOptics AG

In the News

  • In order to end their ongoing legal disputes regarding femtosecond laser assisted cataract surgery devices, including Alcon's LenSx device, which Alcon acquired as part of its acquisition of LenSx Lasers, Inc. in 2010, Alcon Vision LLC the world leader in eye care committed to assisting people see brilliantly, announced that it had entered into a settlement agreement with J&J Surgical Vision, Inc.
     
  • The availability of ACUVUE Abiliti 1-Day Soft Therapeutic Lenses for Myopia Management in Singapore was announced today by Johnson & Johnson Vision Care, Inc., a global pioneer in eye health and division of Johnson & Johnson MedTech.

Author Credits:  Radhika Pawar


  • Report ID: 4856
  • Published Date: Oct 14, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of intraocular lens is assessed at USD 7.01 billion.

The intraocular lens market size was valued at USD 6.57 billion in 2024 and is set to reach USD 18.66 billion by the end of 2037, expanding at around 8.3% CAGR during the forecast period i.e., between 2025-2037. The market growth is driven by growing prevalence of diabetes, rising geriatric population, surge in screen exposure, and others.

North America is projected to have the significant growth by 2037, backed by growing healthcare investment, along with rising prevalence of cataracts in the region.

The major players in the market include Alcon Vision LLC, Johnson & Johnson Vision Care Inc., Bausch Health Companies Inc., Carl Zeiss Meditec AG, HOYA Corporation, Rayner Group, STAAR Surgical Company, PhysIOL SA, Lenstec Inc., HumanOptics AG.
Intraocular Lens Market Report Scope
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample